Pharma sector to benefit from softening of raw material inflation: Cyndrella Carvalho

The pharmaceutical sector is set to benefit from the softening of raw material inflation, according to Cyndrella Carvalho of JM Financial, with an expected 1-1.5% margin revival across the sector. Companies focusing on specialty drugs, such as Sun Pharma, are predicted to offer potential for growth in the market.